Mondelez and Campbell Soup are currently in a deadlock over the sale of the soup company’s Arnott’s cookie brands, one of Mondelez’s international businesses.
Recently, the Oreo's owner had submitted a final bid for Campbell’s international businesses, including Arnott’s. But the bid was modestly below Campbell’s price expectation of $3 billion, resulting in an impasse.
Arnott’s has the interest of some other buyers like KKR, a consortium backed by private equity firm. It is undisclosed what price the private equity firm has offered to buy Arnott, but it is known that they pay less for acquisitions than corporate buyers.
The impasse has put Campbell in an awkward situation, as it may either have to sell Arnott’s below its desired price or abandon the sales process altogether. Last year,Campbell had already put the unit up for sale to help pay down its debt following its $6.2-billion purchase of pretzel and chip company Snyder’s-Lance.
The deadlock also beckons the question of whether the two companies are better off separate than together.
The impasse also poses bigger challenges for the food industry as a number of big brands like Kraft Heinz (KHC), Kellogg (K) and General Mills (GIS) are now focussing on smaller investments on nimbler brands than pay big premiums. Mendelez recently bought premium cookie brand Tate’s Bake Shop for $500 million. Frito-Lay-owner PepsiCo likewise has made small add-ons, recently buying apple chips maker Bare Foods for less than $200 million.
The Aroon Indicator for MDLZ entered a downward trend on September 30, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 221 similar instances where the Aroon Indicator formed such a pattern. In 129 of the 221 cases the stock moved lower. This puts the odds of a downward move at 58%.
The Momentum Indicator moved below the 0 level on September 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MDLZ as a result. In 52 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 52%.
MDLZ moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MDLZ crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDLZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MDLZ's RSI Indicator exited the oversold zone, 15 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 44%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDLZ advanced for three days, in 168 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
MDLZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.884) is normal, around the industry mean (3.067). P/E Ratio (22.043) is within average values for comparable stocks, (21.001). Projected Growth (PEG Ratio) (0.891) is also within normal values, averaging (1.364). Dividend Yield (0.033) settles around the average of (0.019) among similar stocks. P/S Ratio (2.028) is also within normal values, averaging (1.937).
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. MDLZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDLZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of packaged food products
Industry FoodSpecialtyCandy